Next Article in Journal
Anti-Trypanosoma cruzi Activity, Mutagenicity, Hepatocytotoxicity and Nitroreductase Enzyme Evaluation of 3-Nitrotriazole, 2-Nitroimidazole and Triazole Derivatives
Previous Article in Journal
Evaluation of the Anticancer and Biological Activities of Istaroxime via Ex Vivo Analyses, Molecular Docking and Conceptual Density Functional Theory Computations
Previous Article in Special Issue
Multitarget Potential of Phytochemicals from Traditional Medicinal Tree, Terminalia arjuna (Roxb. ex DC.) Wight & Arnot as Potential Medicaments for Cardiovascular Disease: An In-Silico Approach
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Isochlorogenic Acid Glucosides from the Arabian Medicinal Plant Artemisia sieberi and Their Antimicrobial Activities

1
Department of Pharmacognosy, College of Clinical Pharmacy, Baha University, P.O. Box 26553, Taif 3442, Saudi Arabia
2
Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia
3
Department of Pharmaceutics, College of Pharmacy, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia
4
Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 22452, Riyadh 11495, Saudi Arabia
5
Department of Pharmacy, School of Medicine and Surgery, University of Naples Federico II, Via Montesano 49, 80131 Naples, Italy
6
Department of Chemistry, School of Computer, Mathematical and Natural Sciences, Morgan State University, Baltimore, MD 21251, USA
*
Author to whom correspondence should be addressed.
Molecules 2023, 28(22), 7460; https://doi.org/10.3390/molecules28227460
Submission received: 1 October 2023 / Revised: 29 October 2023 / Accepted: 2 November 2023 / Published: 7 November 2023

Abstract

:
A phytochemical investigation of the stems of the Arabian plant Artemisia sieberi afforded three new isochlorogenic acid derivatives, namely isochlorogenic acid A-3′-O-β-glucopyranoside (1), isochlorogenic acid A-3′-O-β-glucopyranoside methyl ester (2), and isochlorogenic acid C-3′-O-β-glucopyranoside (3), obtained along with thirteen known secondary metabolites belonging to distinct structural classes. The structures of the new metabolites were elucidated by modern spectroscopic techniues based on high-resolution mass spectrometry (HR-ESIMS) and 1D/2D nuclear magnetic resonance (NMR). All isolated compounds were tested for their potential antimicrobial activity against four different bacterial strains (Bacillus subtilis, Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa), in addition to a fungal strain (Candida tropicalis), The results were expressed as the diameter of the clear zone (in millimetres) around each well. Compounds 1 and 3 (isochlorogenic acid A-3′-O-β-glucopyranoside and isochlorogenic acid C-3′-O-β-glucopyranoside, respectively) displayed remarkable antifungal effect and potent antibacterial activities against B. subtilis and S. aureus, respectively. 3α,4α-10β-trihydroxy-8α-acetyloxyguaian-12,6α-olide (6) and angelicoidenol 2-O-β-d-glucopyranoside (9) emerged as interesting dual antibacterial (selective on P. aeruginosa)/antifungal agents.

1. Introduction

Artemisia, a heterogeneous genus of the Asteraceae family including more than 400 species, is widely distributed in Europe, Asia, South Africa, and North America as a shrub, mug wort, worm wood, and sage brush. The Kingdom of Saudi Arabia is an immense dry country with an area of around 2,250,000 km2 that covers a large portion of the Arabian Peninsula and hosts a wide variety of plant species and various ecosystems. Plants of the genus Artemisia are represented in Saudi Arabia by seven different species, namely A. monosperma, A. scoparia, A. sieberi, A. herba-alba, A. judaica, A. abyssinica and A. absinthium, many of them have found to be used in the folk medicine since ancient times to treat a great variety of ailments [1].
A. sieberi is a prominent greenish, perennial shrub that grows in open fields, roadsides, valleys, and desert, with 50–150 cm in height, and pedate, pubescent, alternate leaves. It is widespread in the entire Middle East region [2] as a medicinal plant commonly used as anthelmintic, anti-malarial and for the treatment of gangrenous and infectious ulcers [3]. Several studies have supported the antimicrobial [4], antioxidant [5], hepatoprotective and nephroprotective activities and properties of the extracts. A study reported that the ethanolic extract of A. sieberi inhibits angiogenesis both in vitro and in vivo in human umbilical vein endothelial cells and chick chorioallantois membrane models [6].
Although a plethora studies and research work have reported on the composition of the essential oils of this plant, small number of researchers have investigated and explored the phytochemical composition of the plant’s full organic extracts, additionally, none of the activities reported for the extract has been unambiguously associated with a specific metabolite or to a category of compounds. Belonging to the Asteraceae family, it is not surprising that sesquiterpene lactones and flavonoids have been reported as the dominating class of secondary metabolites purified from the medium polarity fractions of the plant extracts. Only a specific and mild antioxidant and antitumor activities have been associated with these compounds [7].
Given the need to complete the phytochemical profile of A. sieberi with an investigation of the polar fractions of the extract, whose composition is, to our knowledge completely unknown, we were prompted to focus on the phytochemical characterization of this important Saudi Artemisia species. Due to the increasing burden of multidrug-resistant strains, there is an urgent worldwide need for new antifungal and antibacterial compounds and agents. To address this issue, we decided to screen the antimicrobial activity and evaluate the biological effects of the purified compounds against five distinct strains of fungi and Gram+ and Gram− bacteria. Our efforts resulted in the characterization of sixteen pure compounds, including three new β-glucopyranoside derivatives of isochlorogenic acids A or C (13, Figure 1), and in the definition of their antimicrobial profile, that gave interesting clues for the development of new antimicrobial agents.

2. Results

The Stems part of A. sieberi were extracted with a hydroethanolic solution and the extracted gummyish material was macerated in water and then subdivided with dichloromethane followed by n-butanol. The non-water soluble parts were chromatographed by using silica gel and then further divided by repeated column and LC fractionations to acquired sixteen compounds (116, Figure 1). These comprised the new compounds isochlorogenic acid A-3′-O-β-glucopyranoside (1), isochlorogenic acid A-3′-O-β-glucopyranoside methyl ester (2), and isochlorogenic acid C-3′-O-β-glucopyranoside (3), and thirteen known secondary metabolites: dehydrodiconiferyl alcohol 9′-β-d-glucopyranoside (4) [8], dehydrodiconiferyl alcohol 4-O-β-d-glucopyranoside (5) [9], 3α,4α-10β-trihydroxy-8α-acetyloxyguaian-12,6α-olide (6), 3α,4α-10β-trihydroxy-guaian-12,6α-olide (7), epi-vulgarin (8) [10], angelicoidenol 2-O-β-d-glucopyranoside (9) [11], betulabuside A (10) [12], skimmin (11), yangambin (12) [13], isoquercetin (13), p-arbutin (14), chlorogenic acid (15) and its methyl ester (16). All the previously known compounds were recognised via correlation of their spectroscopic details with those described in the literature or with those of standards available in our laboratories.
Compound 1 was purified from the butanol soluble fraction as a white powder. The molecular formula of 1 was resloved as C31H34O17 by HR-ESIMS in the negative ion modes (m/z 677.1781, calcd. 677.1791, for C31H33O17). Diagnostic fragmentation peaks were detected at m/z 515 and at m/z 353 and could be compatible with the loss of a caffeoyl and a glycosyl residue, respectively.
The proton NMR spectrum of 1 (Table 1) indicated two sets of mutually coupled doublets (δH 7.45/6.23 and 7.52/6.37) with coupling constants of 15.5 and 16.1 Hz, respectively, indicative of double bond methines with trans configuration, thus supporting the previously hypothesized presence of cinnamyl-type residues. In the aromatic downfield region of the 1H NMR spectrum, resonances of two ABX spin systems, at δH 7.15, 6.98 and 6.77, and at δH 7.09, 7.14 and 7.12, were suggestive of the existance of two 1,3,4-trisubstituted aromatic rings. Once connected to the directly attached carbon atoms via the 2D NMR HSQC spectrum, these signals could be easily attributed to the resonances of two caffeoyl residues. The remaining signals of the 1H NMR spectrum were all located in the middle region and could be only deconvoluted with the help of the 2D NMR COSY spectrum. This revealed the existence of two distinct spin systems: the first included resonances of three different oxymethine protons at δH 3.62, 5.19 and 5.29, along with two pairs of methylene protons at δH 1.84 (2H), 1.97 (1H) and 2.15 (1H), in very good agreement with characteristic resonances reported for quinic acid moieties [14,15]; the second spin system started with the doublet at δH 4.81 (1H), attributale to the anomeric proton of a β-hexopyranose, given its coupling constant of 8.1 Hz. The entire group of 1H NMR signals within this spin system, and especially their coupling constants, could be confidently attributed to a β-glucopyranose. All the proton signals of these moieties were connected with the directly linked carbon atoms through HSQC, further supporting the above assignments. The 13C NMR spectrum also showed resonances of three carbonyl signals at δC 177.9, 166.8 and 166.6, six aromatic carbons, including four oxygenated ones, and an unprotonated oxygenated sp3 carbon resonating at δC 75.3.
The 2D NMR HMBC spectrum provided crucial 2,3JC,H connections to finally assemble the above deduced moieties, (Figure 2). Particularly, the cross-peaks of the downfield shifted H-3 (δH 5.19) and H-5 (δH 5.29) with C-9′ and C-9″, respectively, indicating the esterification sites of the caffeoyl units on the quinic acid core. The structure of this moiety was further supported by the HMBC cross-peaks of the two methylenes H2-2 and H2-6 with the carboxylic acid carbonyl carbon. Since several diastereomers of quinic acid have been reported in previously published literature [15], the configuration of quinic acid residue should be assigned with care. A careful comparison of the experimental facts with those reported for chlorogenic acid by Forino et al. [15], allowed a confident assignment of the configuration of this moiety. The point of connectivity of the sugar moiety was deduced by the 3JC-H HMBC cross-peak detected from the glucosyl anomeric proton at δH 4.81 to C-3 (δC 147.7). Acid hydrolysis of compound 1 allowed the identification of the hexose sugar unit as d-glucoside through the optical sign of its rotation.
Consequently, the structure of 1 was characterized as isochlorogenic acid A-3′-O-β-d-glucopyranoside. The chlorogenic and isochlorogenic acid derivatives represent an important class of natural products, often found in the Asteraceae family, and well known for their bioactivities. Chlorogenic acids have been reported to minimize fasting blood glucose, improve glucose tolerance, enable body weight loss and prevent body weight gain, and promote an improvement in blood pressure in hypertensive patients. In spite of the dozens of chlorogenic acid analogues reported to date, to our updated knowledge, this the first described report of a natural glucosylated derivative of dicaffeoylquinic acid (isochlorogenic acid).
Compound 2 was isolated as white powder with molecular formula C32H36O17, deduced from negative mode HR-ESIMS peak at m/z 691.1872, (calcd. 691.1880, C32H35O17). 1Proton and 13Carbon NMR spectra of compound 2 (see Supplementary Materials) were practically superimposable to those of 1, with the only significant difference of the additional presence of the resonances of a methoxy group (δH 3.58, δC 52.4) and the substitutionof the carboxylic group at C-7 with the resonance of an ester carbonyl group (δC 174.4). The existance of a methyl ester was settled by the 3J HMBC correlation of δH 3.58 with carbonyl carbon at δC 174.4 and its placement secured by the HMBC cross-peaks of H2-2 and H2-6 with the signal of the ester carbonyl. Thus, in agreement with these spectral features, compound 2 could be assigned as the methyl ester of isochlorogenic acid A-3′-O-β-glucopyranoside (1).
Compound 3 showed the similar molecular formula C31H33O17 as compound 1 and also same 1H and 13C NMR spectra (Table 1). Analysis of 2D NMR COSY, HSQC, and HMBC of 3 spectra resulted in the allocation of all the carbon and proton resonances and to the explaination of the same moieties above described for 1 (namely two caffeoyl units, a quinic acid and a β-glucopyranose unit). Thus, given the identity of molecular formula and of moieties deduced by spectral analysis, the difference between 1 and 3 must be confined to a different linkage between these moieties. Interestingly, significant differences were found in the pattern of chemical shifts of the quinic acid unit, where the two downfield shifted (as a result of acylation) oxymethines were now vicinal (H-4 and H-5). This location of the acylating caffeoyl units was further supported by the HMBC cross-peaks of H-4 and H-5 with the corresponding ester carbonyl resonances (C-9′ and C-9″, respectively). Having secured the connectivity point of the sugar unit at C-3′ (HMBC cross peak H-1‴/C-3), the structure of 3 can be assigned as isochlorogenic acid C-3′-O-β-glucopyranoside. This compound could be either a genuine enzymatic product or could be formed as a result of acyl migration on compound 1, a mechanism not uncommon among acylated polyols.
Thirteen known compounds were also isolated from A. sieberi; dehydrodiconiferyl alcohol 9′-β-d-glucopyranoside (4) [8], dehydrodiconiferyl alcohol 4-O-β-d-glucopyranoside (5) [9], 3α,4α-10β-trihydroxy-8α-acetyloxyguaian-12,6α-olide (6), 3α,4α-10β-trihydroxy-guaian-12,6α-olide (7), epi-vulgarin (8) [10], angelicoidenol 2-O-β-d-glucopyranoside (9) [11], betulabuside A (10) [12], skimmin (11), yangambin (12) [13], isoquercetin (13), p-arbutin (14), chlorogenic acid (15), and its methyl ester (16).
Considering that a significant antibacterial activity must be added to the many showed by chlorogenic acid derivatives [16], in the frame of our current interest in the finding of a new generation of antimicrobial lead compounds from plants origin, we decided to evaluate some of the isolated metabolites (excluding those available in insufficient amounts) on a panel of Gram-+, including S. aureus, B. subtilis and Gram−, including E. coli and P. aeruginosa, bacterial strains, in addition to a fungal strain C. tropicalis, which are responsible for human diseases in tropical countries [17]. C. tropicalis has been indicated as the wide spread pathogenic yeast species after C. albicans. Infections due to C. tropicalis have increased dramatically around the world thus declare this organism to be an emerging pathogenic yeast. In general, these strains were also chosen for several reasons (a) the relative ease with which they can be propagated and studied in the laboratory; (b) their easy and fast growth; and (c) their susceptibility to several microbial inhibitors at various concentrations. In addition, our choice includes pathogenic and non-pathogenic microorganisms.
The antimicrobial activity of A. sieberi extracts and compounds was quantitatively and qualitatively assessed by determining their microorganism’s growth inhibition using agar well diffusion method. Growth inhibitory activity was determined by measuring the clear zone around each well in millimetres (mm) on Mueller–Hinton agar (MHA) plates against tested bacteria and sabouraud dextrose agar plate for fungus strains. All experiments were prepared in triplicate (Table 2). Results indicated the highest growth inhibition against B. subtilis was shown by the new compounds 1 and 3, but also 5 and 10 showed distinct activities. P. aeruginosa showed more sensitivity towards the following compounds 4, 6 and 9. We can hypothesize that the relatively lower polarity of these compounds can influence in a significant manner this result. Interestingly, compounds 6 and 9 were also the most active against C. tropicalis with an almost complete inhibition zone observed. Therefore 3α,4α-10β-trihydroxy-8α-acetyloxyguaian-12,6α-olide (6) and angelicoidenol 2-O-β-d-glucopyranoside (9) qualify as interesting dual antibacterial (selective on Gram negative)/antifungal agents. This detected activity also suggests that the antifungal activity is probably not specific but related to an interaction with a specific, although not identified, target. Indeed, of the two related guaianes 6 and 7, differing for the presence or absence of an acetoxy group, respectively, only 6 is active. Similarly, of the two related monoterpene glucosides 9 and betulabuside A (10), differing for the cyclization of the terpeniyl moiety, only 9 is active. The inhibited activity was noted mainly against C. tropicalis with a complete inhibition observed followed by B. subtilis, S. aureus, and P. aeruginosa and the least effect was recorded with E. coli for the isolated compounds; most compounds have shown antibacterial activity against P. aeruginosa.

3. Experimental

3.1. General Experimental Procedures

An MX-500 Bruker spectrometer was utilized to compute 1D (one-dimensional) and 2D (two-dimensional) NMR (nuclear magnetic resonance) spectra. The NMR δ (chemical shifts) were calculated in ppm compare to TMS, based on the residual signal of the deuterated solvent and J scalar coupling constants reported in Hertz (Hz). ESIMS analyses were accomplished on LC/MS Agilent Triple Quadrupole 6410 QQQ mass spectrometer with an ESI ion source (nebulizer gas pressure kept on 60 psi, with 350 °C N2 gas temperature having flow rate 12 L/min), operating in the positive and negative mode of scans of ionization through straight infusion method by using MeOH:H2O (4:6 v/v) with a 0.5 mL/ min of flow rate. Purifications and separations of chemical constituents were accomplished by using the open glass column chromatography either RP-18 or silica gel 70–230 mesh (E. Merck, Darmstadt, Germany). The TLC plates used were pre-coated silica gel 60 F254 and RP-18 (Merck), and the visible spots were noticed under UV light and then spraying with ceric sulphate and sulphuric acid reagents and later by heating at 110 °C on a hot plate (TLC plate heater III, CAMAG, Wilmington, NC, USA). Dragendorff’s alkaloid spraying reagent was utilized to give an orange color. Analytical-grade reagent and solvents were purchased from Sigma-Aldrich (St. Louis, MO, USA). Deuterated NMR methanol (CD3OD) was purchased from Cambridge Isotope Lab (Tewksbury, MA, USA).

3.2. Plant Material

The aerial parts (leaves and stem) of A. sieberi were obtained from the city of Jazan of Saudi Arabia, in March 2019 during the blooming stage and recognized by a plant taxonomist, College of Science, King Saud University, dried and immediately extracted. A voucher document specimen (voucher # 16375) has been saved in the herbarium of the Science College, King Saud University, Riyadh (KSU, Saudi Arabia).

3.3. Extraction and Isolation

The shade dried powdered leaves and stem parts of A. sieberi (leaves 1 kg, and 700 g stems) were ground into powder and extracted by maceration in aqueous ethanol 80% (3 × 2.5 L) till complete exhaustion at room temperature. The crude extract of leaves and stems was filtered and evaporated by using a rotary vacuum evaporator (Buchi, Switzerland) under low pressure at 41 °C to obtain from leaves a dark-green residue (100 g), while the stem a dark brown residue (65 g). The crude extracts were suspended in distilled water and successively extracted by means of liquid–liquid extraction (LLE) with n-hexane, chloroform, ethyl acetate, and n-butanol and the remaining aqueous fraction were lyophilized. The collective fractions were evaporated by a rotary vacuum evaporator to dryness.
The n-BuOH fraction was loaded to Sephadex LH-20 column (3 × 150 cm) eluted with a gradient system of H2O:MeOH, starting with 100% water and gradually decreasing the polarity with MeOH up to 100% MeOH. Similar fractions were combined together. Four main fractions were obtained (A–D), which were purified separately on a on silica gel column eluted with a CHCl3:MeOH gradient system starting with 0% CHCl3 up to 100% methanol. Compounds 7 (3.9 mg), and 8 (0.8 mg) were obtained from the fraction A, compound 9 (3.1 mg) was obtained from fraction B, compounds 11 (0.9 mg) and 12 (0.8 mg), were obtained from fraction C. Compounds 13 (0.9 mg), 14 (0.9 mg), and 15 (4.2 mg) were obtained from fraction D using RP-HPLC.
The EtOAc fraction was loaded to silica gel column and eluted with CHCl3:MeOH system to obtain three main fractions (E1-E2-E3) which were re-chromatographed using silica gel column (1.5 × 120 cm) eluted with gradient system of DCM:MeOH H or CHCl3:MeOH, starting with 100% DCM/CHCl3 and gradient increasing the polarity using MeOH reaching to 100% MeOH, to afford 1 (2.5 mg), 2 (1.8 mg), 3 (2.3 mg), 4 (7.5 mg), 5 (6.8 mg), 6 (5.3 mg), 10 (1.0 mg), and 16 (3.9 mg).

3.3.1. 3-O-(3′-O-caffeoyl glucosyl)-5-O-caffeoylquinic Acid (1)

White powder solid. [α]D-32 (c 0.1 CD3OD). 1H and 13C NMR: see Table 1. (–) HRESIMS: m/z = 677.1781 [M − H]. (677.1791 calcd. for C31H33O17).

3.3.2. 3-O-(3′-O-caffeoyl glucosyl)-5-O-caffeoylquinic Acid Methyl Ester (2)

White powder solid. [α]D-48 (c 0.1 CD3OD). (−) HRESIMS: m/z = 691.1872 [M − H] (699.1880 calcd. for C32H35O17).

3.3.3. 4-O-(3′-O-caffeoyl glucosyl)-5-O-caffeoylquinic Acid (3)

White powder solid. [α]D-39 (c 0.1 CD3OD). 1H and 13C NMR: see Table 1. (–) HRESIMS: m/z = 677.1789 [M − H]. (677.1791 calcd. for C31H33O17).

3.4. Antimicrobial Tests

3.4.1. Strains and Growth Condition

All +/− bacterial strains tested in our research and study were kindly provided by the Microbiology Department at King Khaled University Hospital. Four bacterial Strains both gram+ including B. subtilis (ATCC 6633) and S. aureus (ATCC 29213), and gram—including E. coli (ATCC 25966) and P. aeruginosa (ATCC 27853), in addition to one fungal strain including C. tropicalis (ATCC 66019). All isolates were cultivated on nutrient agar and a bacterial suspension from each isolate of 0.5 McFarland turbidity was produced in 5 mL nutrient broth tubes and Mueller Hinton agar for the antibacterial assays and sabouraud dextrose agar plate for antifungal assay.

3.4.2. Agar Well Diffusion Technique

An antimicrobial evaluation test was performed as described previously. briefly, standard strains were grown for overnight at 37 °C in Nutrient Broth medium. The following day, the suspensions were diluted in Nutrient Broth medium to make This inoculate adjusted to 0.5 McFarland (1 × 106–1 × 108 CFU mL−1). Next, each microbial suspension was lay out on the surface of the Mueller Hinton agar (MHA) plates (for bacterial strains) using an alocohol sterile cotton swab or sabouraud dextrose agar plate for fungal strain. MHA surface was pierced with an alocohol sterile cork borer (6 mm) then, 70 µL of each tested compound (amount 5.0 mg/mL in DMSO) was transferred into all well correspondingly. Plates were incubated overnight aerobically for 18–24 h at 37 °C. Diameters of the microbes inhibition zones were measured around all well and the results were recorded as the average of ternary trials in millimeters. Dimethyl sulfoxide (DMSO) was utilized as a negative control while, while ampicillin (25 µg/mL) and fluconazole (50 µg/mL) were the positive control for the bacterial and fungus strains, respectively.

4. Conclusions

In conclusion, it is important to discover discover alternatives for antimicrobial agents, especially those of plant origin, and screen these medicinal plants for potential compounds for medicinal and industrial purposes. A phytochemical investigation of the polar fractions obtained from the chromatographic separation of the extract of the Saudi plant A. sieberi revealed a complex secondary metabolites chemical profile, including monoterpene glucosides, sesquiterpenes, flavonoid glycosides, lignan, coumarins, etc. The most significant phytochemical result was undoubtedly the isolation and the full characterization of the first glycoside derivatives of isochlorogenic acids A and C (13). Moreover, the acidic derivatives 1 and 3 showed a potent and selective antibacterial activity against B. subtilis, while the methyl ester derivative 2 lost this activity showing only a moderate antibacterial action against S. aureus. The comparison between these two activity profiles reveals that, while insensitive to the caffeoyl acylation position, the antimicrobial activity is dramatically influenced by the presence of a free (non esterified) carboxylic acid group. Although compounds 13 were inactive against C. tropicalis, the guaianolide derivative 6 and angelicoidenol 2-O-β-d-glucopyranoside (9) showed a potent and previously unreported activity against this fungal strain. Since the same compounds were also active against P. aeruginosa, a Gram-negative bacteria responsible for a extensive infections, from respiratory tract infections to skin and urinary tract infections, they qualify as double antibacterial/antifungal lead compounds. This double activity could be extremely beneficial in the treatment of several infections, especially those of the respiratory tract, characterized by co-fungal/bacterial proliferation.
While we are aware that further research is needed to support these preliminary findings, we can confidently state that A. sieberi has the potential to produce a large number of metabolites and compounds with antimicrobial properties. It is necessary to conduct additional investigations to determine the effectiveness of these properties in real-world applications against infections and diseases.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/molecules28227460/s1, Figure S1: 1H NMR spectrum of compound 1 in CD3OD. Figure S2: COSY NMR spectrum of compound 1 in CD3OD. Figure S3: HSQC NMR spectrum of compound 1 in CD3OD. Figure S4: HMBC NMR spectrum of compound 1 in CD3OD. Figure S5: 1H NMR spectrum of compound 2 in DMSO-d6. Figure S6: 1H NMR spectrum of compound 3 in CD3OD.

Author Contributions

Conceptualization, S.P. and A.A.-T.; methodology, K.J. and R.O.; software, J.A.-Q. and N.M.S.M.; validation, O.T.-S., S.I.B. and N.M.S.M.; formal analysis, K.J., H.A. and N.M.S.M.; investigation, K.J., S.I.B. and J.P. resources, A.A.-T. and S.P.; data curation, J.A.-Q.; writing—original draft preparation, S.P. and O.T.-S.; writing—review and editing, J.P., H.A. and R.O.; visualization, S.P.; supervision, S.P. and A.A.-T.; project administration, S.P. and A.A.-T.; funding acquisition, A.A.-T. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by Researchers Supporting Project through Project number (RSP2023R208), King Saud University, Riyadh, Saudi Arabia. O.T.-S. was supported by EU funding within the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (Project no. PE00000007, INF-ACT).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Erel, S.B.; Reznicek, G.; Senol, S.G.; Yavasoglu, N.U.K.; Konyalioglu, S.; Zeybek, A.U. Antimicrobial and antioxidant properties of Artemisia L. species from western Anatolia. Turk. J. Biol. 2012, 36, 75–84. [Google Scholar]
  2. Mahboubi, M. Artemisia sieberi Besser essential oil and treatment of fungal infections. Biomed. Pharmacother. 2017, 89, 1422–1430. [Google Scholar]
  3. Nigam, M.; Atanassova, M.; Mishra, A.P.; Pezzani, R.; Devkota, H.P.; Plygun, S.; Salehi, B.; Setzer, W.N.; Sharif-Rad, J. Bioactive compounds and health benefits of Artemisia species. Nat. Prod. Commun. 2019, 14, 1–17. [Google Scholar]
  4. Mohamed, T.A.; Hegazy, M.E.; El Aty, A.A.; Ghabbour, H.A.; Alsaid, M.S.; Shahat, A.A.; Paré, P.W. Antimicrobial sesquiterpene lactones from Artemisia sieberi. J. Asian Nat. Prod. Res. 2017, 19, 1093–1101. [Google Scholar] [CrossRef] [PubMed]
  5. Mahboubi, M.; Valian, M.; Kazempour, N. Chemical composition, antioxidant, and antimicrobial activity of Artemisia sieberi oils from different parts of Iran and France. J. Essent. Oil Res. 2015, 27, 140–147. [Google Scholar] [CrossRef]
  6. Abdolmaleki, Z.; Arab, A.; Amanpour, S.; Muhammadnejad, S. Anti-angiogenic effects of ethanolic extract of Artemisia sieberi compared to its active substance, artemisinin. Rev. Bras. Farmacogn. 2016, 26, 326–333. [Google Scholar] [CrossRef]
  7. Mohamed, T.A.; Albadry, H.A.; Elshamy, A.I.; Younes, S.H.H.; Shahat, A.A.; El-Wassimy, M.T.; Moustafa, M.F.; Hegazy, M.E. A new Tetrahydrofuran sesquiterpene skeleton from Artemisia sieberi. J. Chin. Chem. Soc. 2021, 68, 338–342. [Google Scholar] [CrossRef]
  8. Adhikari, B.; Devkota, H.P.; Joshi, K.R.; Watanabe, T.; Yahara, S. Two new diacetylene glycosides: Bhutkesoside A and B from the roots of Ligusticopsis wallichiana. Nat. Prod. Res. 2016, 30, 1577–1584. [Google Scholar] [CrossRef] [PubMed]
  9. Attoumbre, J.; Hano, C.; Mesnard, F.; Lamblin, F.; Bensaddek, L.; Raynaud-Le Grandic, S.; Laine, E.; Fliniaux, M.A.; Baltora-Rosset, S. Identification by NMR and accumulation of a neolignan, the dehydrodiconiferyl alcohol-4-β-d-glucoside, in Linum usitatissimum cell cultures. C. R. Chim. 2006, 9, 420–425. [Google Scholar] [CrossRef]
  10. Abegaz, B.; Camps, F.; Coll, J.; Feliz, M.; Jacobsson, U.; Miravitlles, C.; Molins, E.; Torramilans, J. The structures of vulgarin and its isomers: A reinvestigation. Tetrahedron 1986, 42, 6003–6009. [Google Scholar] [CrossRef]
  11. Sunnerheim-Sjöberg, K. (1S,2R,4S,5S)-angelicoidenol-2-O-β-D-glucopyranoside. A moose deterrent compound in Scots pine (Pinus sylvestris L.). J. Chem. Ecol. 1992, 18, 2025–2039. [Google Scholar] [CrossRef] [PubMed]
  12. Yue, J.; Lin, Z.; Wang, D.; Sun, H. A sesquiterpene and other constituents from Erigeron breviscapus. Phytochem. 1994, 36, 717–719. [Google Scholar] [CrossRef]
  13. Morais, L.C.S.L.; Almeida, R.N.; da-Cunha, E.V.N.; da-Silva, M.S.; Barbosa-Filho, J.M.; Gray, A.I. Further lignans from Ocotea duckei. Pharm. Biol. 1999, 37, 144–147. [Google Scholar] [CrossRef]
  14. Flores-Parra, A.; Guiterrez-Avella, D.M.; Contreras, R.; Khuong-Huu, F. 13C and 1H NMR investigations of quinic acid derivatives: Complete spectral assignment and elucidation of preferred conformations. Magn. Res. Chem. 1989, 27, 544–545. [Google Scholar] [CrossRef]
  15. Forino, M.; Tenore, G.C.; Tartaglione, L.; Dell’Aversano, C.; Novellino, E.; Ciminiello, P. (1S,3R,4S,5R)5-O-Caffeoylquinic acid: Isolation, stereo-structure characterization and biological activity. Food Chem. 2015, 178, 306–310. [Google Scholar] [CrossRef] [PubMed]
  16. Chen, K.; Peng, C.; Chi, F.; Yu, C.; Yang, Q.; Li, Z. Antibacterial and antibiofilm activities of chlorogenic acid against Yersinia enterocolitica. Front. Microbiol. 2022, 13, 885092. [Google Scholar] [CrossRef] [PubMed]
  17. Chai, L.Y.A.; Denning, D.W.; Warn, P. Candida tropicalis in human disease. Crit. Rev. Microbiol. 2010, 36, 282–298. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical structures of compounds 116 isolated from the A. sieberi.
Figure 1. Chemical structures of compounds 116 isolated from the A. sieberi.
Molecules 28 07460 g001
Figure 2. Key 1H-1H COSY (blue boldened) and HMBC (red arrow) correlations of 1.
Figure 2. Key 1H-1H COSY (blue boldened) and HMBC (red arrow) correlations of 1.
Molecules 28 07460 g002
Table 1. 1H NMR (500 MHz) and 13C NMR (125 MHz) data for 1 and 3 (in CD3OD).
Table 1. 1H NMR (500 MHz) and 13C NMR (125 MHz) data for 1 and 3 (in CD3OD).
No.1 3
δH (Mult., J in Hz)δcδH (Mult., J in Hz)δc
1 75.3 75.7
2a1.84 (dd, 12.1, 3.2)37.82.01 (dd, 10.5, 3.2)37.0
2b2.15 (d, 12.1, 4.9) 2.09 (dd, 10.5, 5.0)
35.19 (dt, 4.9, 3.2)73.84.30 (bt, 8.5)68.8
43.62 (dd, 8.5, 3.2)70.54.98 (dd, 8.5, 3.2)75.7
55.29 (bt, 8.5)71.65.52 (dt, 4.9, 3.2)68.0
6a1.84 (dd, 12.1, 8.5)39.22.07 (dd, 12.1, 8.5)39.4
6b1.97 (bd, 12.1) 2.14 (bd, 12.1)
7 177.9 176.9
1′ 129.1 128.8
2′7.12 (bs)116.47.12 (m)116.4
3′ 147.7 147.7
4′ 148.9 148.9
5′7.09 (d, 7.1)121.17.05 (d, 7.1)121.9
6′7.14 (bd, 7.1)115.07.11 (bd, 7.1)115.4
7′7.52 (d, 16.1)144.47.53 (d, 15.0)145.3
8′6.37 (d, 16.1)117.46.37 (d, 15.0)116.3
9′ 166.8 166.5
1″ 125.9 125.8
2″7.15 (bs)115.37.06 (m)116.3
3″ 146.1 146.1
4″ 147.2 147.2
5″6.98 (d, 7.0)121.86.99 (d, 7.0)121.4
6″6.77 (d, 7.0)116.26.77 (d, 7.0)116.3
7″7.45 (d, 15.5)145.37.41 (d, 15.0)145.6
8″6.23 (d, 15.5)114.86.17 (d, 15.0)114.3
9″ 166.6 166.5
1‴4.81 (d, 8.1)101.74.79 (d, 8.1)101.7
2‴3.31 (m)73.63.30 (m)73.6
3‴3.31 (m)76.23.30 (m)76.2
4‴3.19 (m)70.13.18 (m)70.1
5‴3.36 (m)77.53.35 (m)77.5
6‴a3.72 (m)61.03.70 (m)61.0
6‴b3.47 (m) 3.47 (m)
Table 2. Antimicrobial activity of test compounds (5.0 mg/mL) expressed as average inhibition zone (in mm).
Table 2. Antimicrobial activity of test compounds (5.0 mg/mL) expressed as average inhibition zone (in mm).
CompoundS. aureus
ATCC 29213
B. subtilis
ATCC 6633
E. coli
ATCC 29213
P. aeruginosa
ATCC 27853
C. tropicalis
ATCC 66019
1-24---
213----
3-22---
4---13-
5-23-99
6---1330
7---11-
9---1530
10-24---
1518----
1613----
Ampicillin68824-
Fluconazole----15
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Jamal, K.; Al-Taweel, A.; Bukhari, S.I.; Orfali, R.; Moubayed, N.M.S.; Al-Qahtani, J.; Aati, H.; Taglialatela-Scafati, O.; Peng, J.; Perveen, S. Isochlorogenic Acid Glucosides from the Arabian Medicinal Plant Artemisia sieberi and Their Antimicrobial Activities. Molecules 2023, 28, 7460. https://doi.org/10.3390/molecules28227460

AMA Style

Jamal K, Al-Taweel A, Bukhari SI, Orfali R, Moubayed NMS, Al-Qahtani J, Aati H, Taglialatela-Scafati O, Peng J, Perveen S. Isochlorogenic Acid Glucosides from the Arabian Medicinal Plant Artemisia sieberi and Their Antimicrobial Activities. Molecules. 2023; 28(22):7460. https://doi.org/10.3390/molecules28227460

Chicago/Turabian Style

Jamal, Khlood, Areej Al-Taweel, Sarah I. Bukhari, Raha Orfali, Nadine M. S. Moubayed, Jawaher Al-Qahtani, Hanan Aati, Orazio Taglialatela-Scafati, Jiangnan Peng, and Shagufta Perveen. 2023. "Isochlorogenic Acid Glucosides from the Arabian Medicinal Plant Artemisia sieberi and Their Antimicrobial Activities" Molecules 28, no. 22: 7460. https://doi.org/10.3390/molecules28227460

APA Style

Jamal, K., Al-Taweel, A., Bukhari, S. I., Orfali, R., Moubayed, N. M. S., Al-Qahtani, J., Aati, H., Taglialatela-Scafati, O., Peng, J., & Perveen, S. (2023). Isochlorogenic Acid Glucosides from the Arabian Medicinal Plant Artemisia sieberi and Their Antimicrobial Activities. Molecules, 28(22), 7460. https://doi.org/10.3390/molecules28227460

Article Metrics

Back to TopTop